Methylation of the BRCA1 promoter occurs in 11–14% [42]–[44] of sporadic breast cancers and in 5–31% [42], [44]–[46] of ovarian cancers and is often associated with LOH [42], [47]. This evidence concerns the gene BRCA1 and breast carcinoma.